I believe that this could be catastrophic in terms of HIV prevention.
Michael Weinstein, president the AIDS Healthcare Foundation. Weinstein was commenting on drugmaker Gilead’s application for FDA approval to market its HIV treatment medication Truvada as a HIV prevention pill. If Truvada is approved for preventive use, it “would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV through sex,” according to a company statement at the time of the filing last month.
Gilead’s application, however, has sparked debate among public health advocates who argue that the wide availability of the drug would discourage safe sex and would, in fact, increase the incidence of HIV.